Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE
暂无分享,去创建一个
M. Dimopoulos | A. Jakubowiak | Shaji K. Kumar | H. Avet-Loiseau | B. Paiva | G. Cook | C. Touzeau | T. Facon | J. San-Miguel | M. Qi | M. Mateos | S. Usmani | M. Cavo | N. Bahlis | J. Ukropec | C. Heuck | Jianping Wang | H. Quach | Steven Sun | R. Kobos | H. Pei | M. Krevvata | R. Van Rampelbergh | Anupa Kudva | P. Ramaswami | M. Qi | Nikki A. Deangelis